EconPapers    
Economics at your fingertips  
 

Stage 3 Prostate Cancer Treated with a Plant-Based Diet A Case Report

Stewart D Rose and Amanda J Strombom
Additional contact information
Amanda J Strombom: Plant-Based Diets in Medicine, USA

Cancer Therapy & Oncology International Journal, 2020, vol. 15, issue 5, 142-143

Abstract: Treatment of early stage prostate cancer (with a Gleason score less than seven) with a plant-based diet has been studied, and efficacy noted even after 5 years. However, this is a case of a patient with Stage 3 prostate cancer, who chose to follow a plant-based diet after his diagnosis, and is still alive today, 32 years later, despite being given a prognosis of 10% 3-year survival. The patient is a retired physician, who was given the best available treatment since his diagnosis in 1987. He also chose to follow a largely plant-based diet after his diagnosis, recognizing its potential for treating prostate cancer. He has outlasted all other patients with a similar diagnosis, who were given the same treatment at his major city-based hospital. He attributes this to his plant-based diet. This is the first case we are aware of where a patient with stage III prostate cancer exceeded his prognosis for 32 years.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555922.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555922.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:15:y:2020:i:5:p:142-143

DOI: 10.19080/CTOIJ.2020.15.555922

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().

 
Page updated 2025-03-19
Handle: RePEc:adp:jctoij:v:15:y:2020:i:5:p:142-143